Background and Purpose: Randomized controlled trials have demonstrated the importance of time to endovascular therapy (EVT) in clinical outcomes in large vessel occlusion (LVO) acute ischemic stroke. Delays to treatment are particularly prevalent when patients require a transfer from hospitals without EVT capability onsite. A computer-aided triage system, Viz LVO, has the potential to streamline workflows. This platform includes an image viewer, a communication system, and an artificial intelligence (AI) algorithm that automatically identifies suspected LVO strokes on CTA imaging and rapidly triggers alerts. We hypothesize that the Viz application will decrease time-to-treatment, leading to improved clinical outcomes. Methods: A retrospective analysis of a prospectively maintained database was assessed for patients who presented to a stroke center currently utilizing Viz LVO and underwent EVT following transfer for LVO stroke between July 2018 and March 2020. Time intervals and clinical outcomes were compared for 55 patients divided into pre- and post-Viz cohorts. Results: The median initial door-to-neuroendovascular team (NT) notification time interval was significantly faster (25.0 min [IQR = 12.0] vs. 40.0 min [IQR = 61.0]; p = 0.01) with less variation (p < 0.05) following Viz LVO implementation. The median initial door-to-skin puncture time interval was 25 min shorter in the post-Viz cohort, although this was not statistically significant (p = 0.15). Conclusions: Preliminary results have shown that Viz LVO implementation is associated with earlier, more consistent NT notification times. This application can serve as an early warning system and a failsafe to ensure that no LVO is left behind.

1.
Goyal
M
,
Menon
BK
,
van Zwam
WH
,
Dippel
DW
,
Mitchell
PJ
,
Demchuk
AM
, et al
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
.
Lancet
.
2016
;
387
(
10029
):
1723
31
. .
2.
Saver
JL
,
Goyal
M
,
van der Lugt
A
,
Menon
BK
,
Majoie
CB
,
Dippel
DW
, et al
Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis
.
JAMA
.
2016
;
316
(
12
):
1279
88
. .
3.
Murray
NM
,
Unberath
M
,
Hager
GD
,
Hui
FK
.
Artificial intelligence to diagnose ischemic stroke and identify large vessel occlusions: a systematic review
.
J Neurointerv Surg
.
2020
;
12
(
2
):
156
64
. .
4.
Yaeger
KA
,
Martini
M
,
Yaniv
G
,
Oermann
EK
,
Costa
AB
.
United States regulatory approval of medical devices and software applications enhanced by artificial intelligence
.
Health Policy Technol
.
2019
;
8
(
2
):
192
7
. .
5.
Wei
D
,
Oxley
TJ
,
Nistal
DA
,
Mascitelli
JR
,
Wilson
N
,
Stein
L
, et al
Mobile interventional stroke teams lead to faster treatment times for thrombectomy in large vessel occlusion
.
Stroke
.
2017
;
48
(
12
):
3295
300
. .
6.
McVerry
F
,
Hunter
A
,
Dynan
K
,
Matthews
M
,
McCormick
M
,
Wiggam
I
, et al
Country-wide analysis of systemic factors associated with acute ischemic stroke door to needle time
.
Front Neurol
.
2019
;
10
:
676
. .
7.
McKinney
JS
,
Mylavarapu
K
,
Lane
J
,
Roberts
V
,
Ohman-Strickland
P
,
Merlin
MA
.
Hospital prenotification of stroke patients by emergency medical services improves stroke time targets
.
J Stroke Cerebrovasc Dis
.
2013
;
22
(
2
):
113
8
. .
8.
Ospel
JM
,
Almekhlafi
MA
,
Menon
BK
,
Kashani
N
,
Chapot
R
,
Fiehler
J
, et al
Workflow patterns and potential for optimization in endovascular stroke treatment across the world: results from a multinational survey
.
J Neurointerv Surg
.
2020 Dec 12
;
12
(
12
):
1194
8
.
9.
Williams
MM
,
Wilson
TA
,
Leslie-Mazwi
T
,
Hirsch
JA
,
Kellogg
RT
,
Spiotta
AM
, et al
The burden of neurothrombectomy call: a multicenter prospective study
.
J Neurointerv Surg
.
2018
;
10
(
12
):
1143
8
. .
10.
Powers
WJ
,
Rabinstein
AA
,
Ackerson
T
,
Adeoye
OM
,
Bambakidis
NC
,
Becker
K
, et al
Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
.
Stroke
.
2019
;
50
(
12
):
e344
418
. .
11.
Yaeger
KA
,
Shoirah
H
,
Kellner
CP
,
Fifi
J
,
Mocco
J
.
Emerging technologies in optimizing pre-intervention workflow for acute stroke
.
Neurosurgery
.
2019
;
85
(
Suppl 1
):
S9
17
. .
12.
FDA approves stroke-detecting AI software
.
Nat Biotechnol
.
2018
;
36
(
4
):
290
.
13.
Chatterjee
A
,
Somayaji
NR
,
Kabakis
IM
.
Abstract WMP16: artificial intelligence detection of cerebrovascular large vessel occlusion: nine month, 650 patient evaluation of the diagnostic accuracy and performance of the viz.ai LVO algorithm
.
Stroke
.
2019
;
50
(
Suppl 1
):
AWMP16
. .
14.
Czap
AL
,
Singh
N
,
Bowry
R
,
Jagolino-Cole
A
,
Parker
SA
,
Phan
K
, et al
Mobile stroke unit computed tomography angiography substantially shortens door-to-puncture time
.
Stroke
.
2020
;
51
(
5
):
1613
5
. .
15.
Schlemm
L
,
Endres
M
,
Nolte
CH
.
Bypassing the closest stroke center for thrombectomy candidates: what additional delay to thrombolysis is acceptable?
Stroke
.
2020
;
51
(
3
):
867
75
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.